Diovan Clinical Trials This is an RSS file. You can use it to subscribe to this data in your favourite RSS reader or to display this data on your own website or blog.

• News
• Research
• Blogs
• Podcasts
• Alerts
• Clinical Trials
• Forums

Candesartan Cilexetil + Chlorthalidone + Amlodipine Versus Exforge HCT ®️ for Systemic Arterial Hypertension
Condition:   Hypertension Interventions:   Drug: candesartan cilexetil + chlorthalidone + amlodipine;   Drug: Exforge HCT® (valsartan 160mg + hydrochlorothiazide 12.5mg + amlodipine 5mg) Sponsors:   Hospital Israelita Albert Einstein;   Libbs Farmacêutica LTDA Not yet recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - June 27, 2023 Category: Research Source Type: clinical trials